GB0204720D0 - Novel use - Google Patents

Novel use

Info

Publication number
GB0204720D0
GB0204720D0 GBGB0204720.7A GB0204720A GB0204720D0 GB 0204720 D0 GB0204720 D0 GB 0204720D0 GB 0204720 A GB0204720 A GB 0204720A GB 0204720 D0 GB0204720 D0 GB 0204720D0
Authority
GB
United Kingdom
Prior art keywords
novel use
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0204720.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0204720.7A priority Critical patent/GB0204720D0/en
Publication of GB0204720D0 publication Critical patent/GB0204720D0/en
Priority to PCT/EP2003/002039 priority patent/WO2003072198A1/en
Priority to AU2003215606A priority patent/AU2003215606A1/en
Priority to TW092103971A priority patent/TW200406207A/en
Priority to ARP030100635A priority patent/AR038847A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
GBGB0204720.7A 2002-02-28 2002-02-28 Novel use Ceased GB0204720D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0204720.7A GB0204720D0 (en) 2002-02-28 2002-02-28 Novel use
PCT/EP2003/002039 WO2003072198A1 (en) 2002-02-28 2003-02-26 The use of a benzenesulfonamide compound in the treatment of obesity
AU2003215606A AU2003215606A1 (en) 2002-02-28 2003-02-26 The use of a benzenesulfonamide compound in the treatment of obesity
TW092103971A TW200406207A (en) 2002-02-28 2003-02-26 Novel use
ARP030100635A AR038847A1 (en) 2002-02-28 2003-02-26 USE OF COMPOUND N- (3,5-DICLORO-2-METOXI-PHENYL) -4-METOXI-3-PIPERAZIN-1-IL-BENCENOSULFONAMIDE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION AND SUCH PHARMACEUTICAL COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0204720.7A GB0204720D0 (en) 2002-02-28 2002-02-28 Novel use

Publications (1)

Publication Number Publication Date
GB0204720D0 true GB0204720D0 (en) 2002-04-17

Family

ID=9931985

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0204720.7A Ceased GB0204720D0 (en) 2002-02-28 2002-02-28 Novel use

Country Status (5)

Country Link
AR (1) AR038847A1 (en)
AU (1) AU2003215606A1 (en)
GB (1) GB0204720D0 (en)
TW (1) TW200406207A (en)
WO (1) WO2003072198A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0303480D0 (en) 2003-12-19 2003-12-19 Biovitrum Ab Benzofuranes
EP1666467A1 (en) * 2004-11-08 2006-06-07 Evotec AG 11Beta-HSD1 Inhibitors
WO2009082268A2 (en) 2007-12-21 2009-07-02 Alla Chem, Llc LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316450B1 (en) * 1997-07-11 2001-11-13 Smithkline Beecham P.L.C. Compounds
SE0002739D0 (en) * 2000-07-21 2000-07-21 Pharmacia & Upjohn Ab New use
GB0021450D0 (en) * 2000-08-31 2000-10-18 Smithkline Beecham Plc Novel compounds
KR100889718B1 (en) * 2001-06-11 2009-03-23 바이오비트럼 에이비(피유비엘) Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ? diabetes

Also Published As

Publication number Publication date
AU2003215606A1 (en) 2003-09-09
AR038847A1 (en) 2005-01-26
WO2003072198A1 (en) 2003-09-04
TW200406207A (en) 2004-05-01

Similar Documents

Publication Publication Date Title
IL166084A0 (en) Novel benzodioxoles
PL371678A1 (en) Novel pyridin- and pyrimidin-derivatives
PL373598A1 (en) Novel benzonaphthyridines
PL372902A1 (en) New use
GB0227666D0 (en) Use
GB0206048D0 (en) Use
IL163529A0 (en) Novel spinosyn-producing polyketidesynthases
GB0217056D0 (en) Use
GB0213878D0 (en) Use
IL164975A0 (en) Novel combination
GB0214784D0 (en) Novel combination
GB0206838D0 (en) Use
GB0204720D0 (en) Novel use
GB0230343D0 (en) Use
GB0210682D0 (en) Novel use
GB0229743D0 (en) Novel benzoxazocines
GB0229442D0 (en) Use
GB0215011D0 (en) Easy squeezy
GB0327195D0 (en) Novel use
GB0217293D0 (en) Novel use
GB0215394D0 (en) Novel use
GB0211290D0 (en) Novel use
GB0205027D0 (en) Novel use
GB0204759D0 (en) Novel use
GB0222408D0 (en) Use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)